ARCHIVES

Litton Sells Clinical Labs, Planning to Join Recompetition For FCRF Contracts

This article is from The Cancer Letter archive.

Vol. 11 No. 28 | July 12, 1985

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 3 Issue 1, Winter 1989

January 13, 1989

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

NIH Defines Misconduct

December 9, 1994

Waxman’s Cancer Act Renewal Legislation: More Pluses Than Minuses; Hearing Scheduled Feb. 25

February 22, 1980

FDA Approves Generic Capecitabine

September 20, 2013